Co-Diagnostics Inc (LTS:0A50)
$ 1.24 0.04 (3.33%) Market Cap: 38.61 Mil Enterprise Value: -3.69 Mil PE Ratio: 0 PB Ratio: 0.55 GF Score: 48/100

Q4 2023 Co-Diagnostics Inc Earnings Call Transcript

Mar 14, 2024 / 08:30PM GMT
Release Date Price: $1.16 (-0.92%)
Operator

Good day and welcome to the Co-Diagnostics Fourth Quarter and Full Year 2023 earnings conference call. All participants will be in listen only mode. Should you need assistance please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question. You may press star then one on your touchtone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Andrew Benson, Investor Relations. Please go ahead.

Andrew Benson
Co-Diagnostics, Inc. - IR

Good afternoon, everyone. Thank you all for participating in today's conference call. On the line today from Co-Diagnostics, we have Dwight Egan, Chief Executive Officer, and Brian Brown, Chief Financial Officer.

Earlier today, Co-Diagnostics released financial results for the fourth quarter and full year ended December 31, 2023. A copy of the press release is available on the company's website. We will begin the call with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot